Integrative Physiology/Experimental Medicine Therapeutic Neovascularization by Nanotechnology- Mediated Cell-Selective Delivery of Pitavastatin Into the Vascular Endothelium

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study.

  2007cited by this paper
• Nonendothelial Mesenchymal Cell–Derived MCP-1 Is Required for FGF-2–Mediated Therapeutic Neovascularization: Critical Role of the Inflammatory/Arteriogenic Pathway

  2006cited by this paper
• Endothelial Progenitor Cells: Characterization and Role in Vascular Biology Bone Marrow–Derived Cells for Enhancing Collateral Development: Mechanisms, Animal Data, and Initial Clinical Experiences Influence of Mechanical, Cellular, and Molecular Factors on Collateral Artery Growth (Arteriogenesis)

  2004cited by this paper
• Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.

  2004cited by this paper
• Blockade of Vascular Endothelial Growth Factor Suppresses Experimental Restenosis After Intraluminal Injury by Inhibiting Recruitment of Monocyte Lineage Cells

  2004cited by this paper
• Cholesterol-Lowering Independent Regression and Stabilization of Atherosclerotic Lesions by Pravastatin and by Antimonocyte Chemoattractant Protein-1 Therapy in Nonhuman Primates

  2004cited by this paper
• Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies.

  2004cited by this paper
• Statins Augment Collateral Growth in Response to Ischemia but They Do Not Promote Cancer and Atherosclerosis

  2004cited by this paper
• Gene Transfer of Stromal Cell–Derived Factor-1&agr; Enhances Ischemic Vasculogenesis and Angiogenesis via Vascular Endothelial Growth Factor/Endothelial Nitric Oxide Synthase–Related Pathway: Next-Generation Chemokine Therapy for Therapeutic Neovascularization

  2004cited by this paper
• Essential Role of Vascular Endothelial Growth Factor and Flt-1 Signals in Neointimal Formation After Periadventitial Injury

  2004cited by this paper
• Factors Regulating Arteriogenesis

  2003cited by this paper
• Double-Edged Role of Statins in Angiogenesis Signaling

  2002cited by this paper
• Vascular Endothelial Growth Factor Is Necessary in the Development of Arteriosclerosis by Recruiting/Activating Monocytes in a Rat Model of Long-Term Inhibition of Nitric Oxide Synthesis

  2002cited by this paper
• Characterization of nanoparticle uptake by endothelial cells.

  2002cited by this paper
• ERRATA

  2001cited by this paper
• HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.

  2001cited by this paper
• Endothelial nitric oxide synthase is essential for the HMG‐CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia

  2001cited by this paper
• Antiinflammatory and Antiarteriosclerotic Actions of HMG-CoA Reductase Inhibitors in a Rat Model of Chronic Inhibition of Nitric Oxide Synthesis

  2001cited by this paper
• HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.

  2001cited by this paper
• Vascular endothelial growth factor enhances atherosclerotic plaque progression

  2001cited by this paper
• Statins' benefits begin to sprout.

  2001cited by this paper
• Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

  2001cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Clinical applications of angiogenic growth factors and their inhibitors

  1999cited by this paper
• Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods.

  1999cited by this paper
• Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.

  1998cited by this paper
• Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (hemagglutinating virus of Japan) liposomes: an effective tool for the in vivo study of arterial diseases.

  1996cited by this paper

• Fluvastatin enhances healing of medication−related osteonecrosis of the jaw (MRONJ) via macrophage polarization in a rat MRONJ−like model

  2025cites this paper
• Therapeutic angiogenesis and tissue revascularization in ischemic vascular disease

  2023cites this paper
• Selective delivery of pitavastatin-loaded nanoparticles induces arteriogenesis upon chronic myocardial ischemia

  2022cites this paper
• Targeted Strategy in Lipid-Lowering Therapy

  2022cites this paper
• Polymers and Nanoparticles for Statin Delivery: Current Use and Future Perspectives in Cardiovascular Disease

  2021cites this paper
• A comprehensive review on the lipid and pleiotropic effects of pitavastatin.

  2021cites this paper
• Pitavastatin stimulates retinal angiogenesis via HMG-CoA reductase-independent activation of RhoA-mediated pathways and focal adhesion

  2021cites this paper
• Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apoe −/− Mice

  2021cites this paper
• Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I/IIa Clinical Trial

  2021cites this paper
• Therapeutic Arteriogenesis/Angiogenesis for Peripheral Arterial Disease by Nanoparticle-Mediated Delivery of Pitavastatin into Vascular Endothelial Cells

  2020cites this paper
• Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats.

  2018cites this paper
• Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models

  2018cites this paper
• Repurposing of statins via inhalation to treat lung inflammatory conditions

  2018cites this paper
• Preclinical evaluation of a paclitaxel-incorporated nanoparticle-coated balloon in rabbit and porcine models.

  2017cites this paper
• Drug Delivery and Nanoformulations for the Cardiovascular System.

  2017cites this paper
• Pitavastatin nanoparticle-engineered endothelial progenitor cells repair injured vessels

  2017cites this paper
• Nanoparticle-Mediated Endothelial Cell-Selective Drug Delivery System

  2017cites this paper
• Therapeutic angiogenesis by local sustained release of microRNA‐126 using poly lactic‐co‐glycolic acid nanoparticles in murine hindlimb ischemia

  2017cites this paper
• Conjunctival lymphoma during pregnancy: a case report

  2017cites this paper
• Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice

  2017cites this paper
• Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening

  2016cites this paper
• Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation

  2016cites this paper
• Anti-inflammatory Nanoparticle for Prevention of Atherosclerotic Vascular Diseases.

  2016cites this paper
• A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model

  2016cites this paper
• Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE −/− Mice

  2016cites this paper
• Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems

  2015cites this paper
• A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model

  2015cites this paper
• Acceleration of hard and soft tissue healing in the oral cavity by a single transmucosal injection of fluvastatin-impregnated poly (lactic-co-glycolic acid) microspheres. An in vitro and rodent in vivo study

  2015cites this paper
• Nanoparticle-mediated drug delivery system for coronary artery disease

  2015cites this paper
• Nanotechnology-mediated drug targeting for the development of innovative therapeutic strategies in treatment-refractory Cardiovascular diseases

  2014cites this paper
• Nanoparticle-Mediated Delivery of Pitavastatin Inhibits Atherosclerotic Plaque Destabilization/Rupture in Mice by Regulating the Recruitment of Inflammatory Monocytes

  2014cites this paper
• Expanding the therapeutic potential of statins by means of nanotechnology enabled drug delivery systems.

  2014cites this paper
• Nanoparticle-mediated drug delivery system for cardiovascular disease.

  2014cites this paper
• Impact of Nanotechnology on Therapeutic Angiogenesis

  2013cites this paper
• Improving treatment of stroke through nanotechnology

  2013cites this paper
• Murine Model of Hindlimb Ischemia Nanoparticle-Mediated Delivery of Pioglitazone Enhances Therapeutic Neovascularization

  2012cites this paper
• Mixing of the old with the new: nanoparticle-mediated pioglitazone delivery to enhance therapeutic neovascularization.

  2012cites this paper
• Nanoparticle-Mediated Delivery of Pioglitazone Enhances Therapeutic Neovascularization in a Murine Model of Hindlimb Ischemia

  2012cites this paper
• Therapeutic effect of local administration of low‐dose simvastatin‐conjugated gelatin hydrogel for fracture healing

  2012cites this paper
• Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus

  2011cites this paper
• Standardization of models and methods used to assess nanoparticles in cardiovascular applications.

  2011cites this paper
• Imatinib mesylate-incorporated nanoparticle-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries.

  2011cites this paper
• Nanomedicine in Cardiovascular Diseases: Emerging Diagnostic and Therapeutic Potential

  2011cites this paper
• Nanoparticle-Mediated Delivery of Pitavastatin Into Lungs Ameliorates the Development and Induces Regression of Monocrotaline-Induced Pulmonary Artery Hypertension

  2011cites this paper
• Pleiotropic effects of pitavastatin

  2011cites this paper
• Treatment Options for Hypercholesterolemia and Combined Dyslipidemia: Focus on Pitavastatin

  2011cites this paper
• Emerging technologies for enabling proangiogenic therapy

  2011cites this paper
• Atorvastatin prevents ischemic limb loss in type 2 diabetes: role of p53.

  2011cites this paper
• Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis

  2010cites this paper
• Insights into Atherosclerosis Using Nanotechnology

  2010cites this paper
• Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia.

  2010cites this paper
• Overview on Nanotechnology and Angiogenesis in Major Diseases Processes

  2010cites this paper
• Cardiovascular risk factors and collateral artery formation

  2009cites this paper
• Local drug delivery systems for enhancement of collateral growth

  2009cites this paper
• How do poly lactide-co-glycolide microspheres for prostaglandin E1 operate in ischemic tissue? Local sustained release of prostaglandin E1 induces neovascularization in murine hindlimb ischemia.

  2009cites this paper
• Nanoparticle-mediated Delivery of Pitavastatin Inhibits Atherosclerotic Plaque Destabilization/rupture in Mice by Regulating the Recruitment of Inflammatory Monocytes Running Title: Katsuki Et Al.; Statin Nanoparticles Inhibit Plaque Rupture

  year unknowncites this paper